Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice.
about
The obesity of boneOvernutrition, mTOR signaling, and cardiovascular diseases.The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in MiceNovel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal WomenType 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies.Characterization of serum proteins attached to distinct sol-gel hybrid surfaces.Structural properties of fracture haematoma: current status and future clinical implications.A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice.Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice.Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing.Proteomic analysis of silica hybrid sol-gel coatings: a potential tool for predicting the biocompatibility of implants in vivo.Proteome analysis of human serum proteins adsorbed onto different titanium surfaces used in dental implants.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.A small-molecule PAI-1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency-induced osteoporosis model.Stromal cell-derived factor-1 mediates changes of bone marrow stem cells during the bone repair process.
P2860
Q26775713-F18728E4-C662-402E-B5E4-20CFC0138069Q34519316-FF5A108A-60C3-4601-A74A-26BFA67CB676Q35500642-DC7DD852-E375-46F7-8823-C5F6D5A5BBE9Q36039605-0C017BC7-AE8D-4EAA-B627-568DED8C787BQ37534744-0B9F6BA5-2553-423D-8853-23D0C2A90BA3Q37716849-C154EA15-B34E-4676-8B52-846D6FE1105DQ38662982-43DD9D8C-0126-4A73-9059-2A38EF661BC1Q38843077-DEA2179A-7EE1-4017-80A6-3DEF538324AEQ39658243-11D746EB-3E89-4402-AA5C-85B03E24A8F3Q41279300-B58CB574-A2C8-4236-B9CD-E914963BE442Q47155974-11934DB5-29B3-4680-8F6C-C49582D163B0Q47717013-2D0A35DD-6D35-4557-B0BD-268D2688AB91Q51069183-0002A39A-3D96-4061-99C6-3377E7B08C26Q51361802-9468D3BB-DB2D-4294-8255-B044B1FF8272Q52597483-5FE1C4EF-F8E2-4BE4-830B-C37A857B7134Q53290264-EF9DB2FA-4B8A-40DB-8880-15E33E7866B8
P2860
Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasminogen activator inhibito ...... with diabetes in female mice.
@ast
Plasminogen activator inhibito ...... with diabetes in female mice.
@en
type
label
Plasminogen activator inhibito ...... with diabetes in female mice.
@ast
Plasminogen activator inhibito ...... with diabetes in female mice.
@en
prefLabel
Plasminogen activator inhibito ...... with diabetes in female mice.
@ast
Plasminogen activator inhibito ...... with diabetes in female mice.
@en
P2093
P2860
P1433
P1476
Plasminogen activator inhibito ...... with diabetes in female mice.
@en
P2093
Hiroshi Kaji
Katsumi Okumoto
Kiyotaka Okada
Masato Yano
Yukinori Tamura
P2860
P304
P356
10.1371/JOURNAL.PONE.0092686
P407
P577
2014-03-20T00:00:00Z